Characterization of Full-Length Genomes of Hepatitis B Virus Quasispecies in Sera of Patients at Different Phases of Infection

• Published in: Journal of clinical microbiology 2015-07, Vol.53 (7), p.2203-2214
• Main Authors: Yang, Zhi-Tao, Huang, Su-Yuan, Chen, Li, Liu, Feng, Cai, Xiao-Hui, Guo, Yang-Fan, Wang, Ming-Jie, Han, Yue, Yu, De-Min, Jiang, Jie-Hong, Zhang, Dong-Hua, Gong, Qi-Ming, Zhang, Guo-Qing, Zang, Guo-Qing, Lu, Zhong-Hua, Huang, Li-Hua, Zhang, Xin-Xin
• Format: Article
• Language: English
• Subjects: Epitopes - genetics; Genetic Variation; Genome, Viral; Genotype; Hepatitis B - pathology; Hepatitis B - virology; Hepatitis B Antigens - genetics; Hepatitis B virus; Hepatitis B virus - classification; Hepatitis B virus - genetics; Hepatitis B virus - isolation & purification; Humans; Mutation Rate; Mutation, Missense; Sequence Deletion; Virology
• ISSN: 0095-1137; 1098-660X
• DOI: 10.1128/JCM.00068-15

Hepatitis B virus (HBV) infection results in different clinical presentation due to different levels of immune response. Our study aimed to characterize HBV full-length genome quasispecies (QS) in patients with different phases of infection to better understand its pathogenesis. Forty treatment-naive HBV-infected patients were enrolled, including 10 cases of acute hepatitis B (AHB), 9 cases of immunotolerant (IT) HBV carriers, 11 cases of chronic hepatitis B (CHB), and 10 cases of acute-on-chronic liver failure (ACLF). The present study was conducted by clone-based sequencing. QS heterogeneity within each open reading frame was calculated. The mutation frequency index (MFI) and amino acid variations within the large HBsAg, HBcAg, and HBxAg regions were analyzed based on the different infection phases. In total, 606 HBV full-length sequences were obtained. HBV QS had higher heterogeneity in ACLF and CHB than that in IT among chronically infected individuals. AHB patients had the lower QS heterogeneity at onset than those with chronic infection. ACLF patients had the highest frequency of mutations in the core promoter and precore region. A triple mutation (A1762T/G1764A/G1896A) was observed more frequently in genotype C than in genotype B. The MFI indicated that specific peptides of the studied regions had more frequent mutations in ACLF. Furthermore, several amino acid variations, known as T- and B-cell epitopes, were potentially associated with the immunoactive phase of infection. More HBV genome mutations and deletions were observed in patients with more severe diseases, particularly in specific regions of the core and preS regions, the clinical significance and mechanism of which need to be further investigated.